Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$76.5M |
| 2 |
Cigna
CI
|
+$56M |
| 3 |
Clarivate
CLVT
|
+$48.2M |
| 4 |
Corteva
CTVA
|
+$26.5M |
| 5 |
Warner Bros
WBD
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$149M |
| 2 |
McKesson
MCK
|
+$101M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$64.5M |
| 4 |
Lennox International
LII
|
+$59.8M |
| 5 |
Tenet Healthcare
THC
|
+$56.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.66% |
| 2 | Technology | 19.2% |
| 3 | Materials | 7.49% |
| 4 | Industrials | 6.59% |
| 5 | Consumer Discretionary | 5.51% |
Similar funds
Glenview Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Glenview Capital Management held 61 positions worth $4.44B, down 2.7% from $4.56B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Glenview Capital Management withdrew a net $598M in Q2 2023, closing 12 positions and reducing 20 holdings. Its most notable exit was Lennox International, an estimated $59.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Materials.
Against the trend, Glenview Capital Management opened a new position in Warner Bros worth $20.4M.
- Glenview Capital Management's largest Q2 2023 buy was Warner Bros: 1,624,300 shares worth $20.4M.
- Glenview Capital Management added most to Universal Health Services in Q2 2023, an estimated $76.5M increase.
- Glenview Capital Management's biggest Q2 2023 reduction was Fiserv Inc, cutting an estimated $149M.
- Glenview Capital Management fully exited Lennox International in Q2 2023, selling an estimated $59.8M.
- Glenview Capital Management's ten largest holdings make up 66% of its $4.44B portfolio in Q2 2023.
- Glenview Capital Management opened 7 new positions and closed 12 in Q2 2023.
- Glenview Capital Management's portfolio value fell 2.7% quarter-over-quarter to $4.44B.
Based on Glenview Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.